QLT Announces Fourth Quarter and Year End 2010 Results
March 01, 2011 06:30 ET
|
QLT Inc.
VANCOUVER, British Columbia, March 1, 2011 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") today reported financial results for the fourth quarter ended December 31,...
QLT Chief Medical Officer Steps Down
February 23, 2011 06:30 ET
|
QLT Inc.
VANCOUVER, British Columbia, Feb. 23, 2011 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") today announced the departure of Dipak Panigrahi, MD, Senior Vice President,...
QLT Receives Positive Opinions for Orphan Drug Designation by the European Medicines Agency for QLT091001 to Treat Two Hereditary Blindness Diseases
February 10, 2011 06:30 ET
|
QLT Inc.
VANCOUVER, British Columbia, Feb. 10, 2011 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") today announced that QLT091001, an oral synthetic retinoid, has received...
QLT Announces Phase II Clinical Trial Results for the Olopatadine Punctal Plug Delivery System (O-PPDS)
February 09, 2011 06:30 ET
|
QLT Inc.
VANCOUVER, British Columbia, Feb. 9, 2011 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") today announced results from a Phase II proof-of-concept clinical trial for the...
QLT Announces Toronto Stock Exchange Approval of Share Repurchase Program
December 10, 2010 06:30 ET
|
QLT Inc.
VANCOUVER, British Columbia, Dec. 10, 2010 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") announced today that the Toronto Stock Exchange ("TSX") has accepted the notice...
QLT Announces Share Repurchase Program
December 08, 2010 06:30 ET
|
QLT Inc.
VANCOUVER, British Columbia, Dec. 8, 2010 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") announced today that its board of directors has approved the repurchase of up to...
QLT Receives Orphan Drug Designation for QLT091001 to Treat Retinitis Pigmentosa
December 07, 2010 16:02 ET
|
QLT Inc.
VANCOUVER, British Columbia, Dec. 7, 2010 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") today announced that QLT091001, the Company's oral synthetic retinoid, has been...
QLT Receives Orphan Drug Designation for QLT091001 to Treat Leber Congenital Amaurosis
December 07, 2010 16:01 ET
|
QLT Inc.
VANCOUVER, British Columbia, Dec. 7, 2010 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") today announced that the U.S. Food and Drug Administration (FDA) has granted...
QLT Ophthalmics, Inc. Establishes an Activis PDT Laser Co-Promotion Agreement With Quantel Medical and Quantel USA in the United States
November 29, 2010 06:30 ET
|
QLT Inc.
VANCOUVER, British Columbia, Nov. 29, 2010 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) today announced that its wholly-owned U.S. subsidiary, QLT Ophthalmics, Inc. ("QOI"), and Quantel...
QLT Announces Third Quarter Results for 2010
November 03, 2010 06:30 ET
|
QLT Inc.
VANCOUVER, British Columbia, Nov. 3, 2010 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") today reported financial results for the third quarter ended September 30, 2010....